Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: GENEREX BIOTECHNOLOGY CORP

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GENEREX BIOTECHNOLOGY CORP in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of GENEREX BIOTECHNOLOGY CORP since year 2005. Table 2 shows the detailed insider transactions of GENEREX BIOTECHNOLOGY CORP since 2005. The reporting company's ticker symbol is GNBT. The reporting company's CIK number is 1059784.

The total value of stock buying since 2005 is $251,951. The total value of stock sales is $262,593. The total value of stock exercises is $342,500.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at GENEREX BIOTECHNOLOGY CORP (GNBT) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $272,500

    $27,250

    $2,725

    $272

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at GENEREX BIOTECHNOLOGY CORP (GNBT) in the past 24 months. See table 2 for insider transaction details.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $1.15

    $.86

    $.58

    $.29



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for GENEREX BIOTECHNOLOGY CORP (GNBT).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-04 0 0 228,342 262,593 300,000 272,500
2008-03 2,700 2,862 0 0 0 0
2008-02 0 0 0 0 70,000 70,000
2006-03 29,100 93,609 0 0 0 0
2006-02 70,000 154,700 0 0 0 0
2005-08 1,000 780 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for GENEREX BIOTECHNOLOGY CORP (GNBT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-04-18 Fletcher Mark (VP & General Counsel) Sale 228,342 1.15 262,593
2008-04-18 Fletcher Mark (VP & General Counsel) Option Exercise 250,000 .89 222,500
2008-04-08 Bernstein Gerald (VP, Medical Affairs) Option Exercise 50,000 1.00 50,000
2008-03-11 Masterson Nola E (Director) Purchase 2,700 1.06 2,862
2008-02-27 Barratt John P (Director) Option Exercise 70,000 1.00 70,000
2006-03-27 Mcgee Brian (Director) Purchase 26,000 3.22 83,720
2006-03-20 Allport Settle Mindy J (Director) Purchase 3,100 3.19 9,889
2006-02-28 Mcgee Brian (Director) Purchase 70,000 2.21 154,700
2005-08-05 Amanatides Peter (Director) Purchase 1,000 .78 780

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of GENEREX BIOTECHNOLOGY CORP (symbol GNBT, CIK number 1059784) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.